Global Lithotripsy Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• March 2022, Shockwave Medical, Inc. globally launched its new peripheral intravascular lithotripsy (IVL) catheter, the Shockwave M5+ peripheral IVL catheter, after receiving both CE Mark and USFDA clearance. This device is specifically designed to reduce IVL treatment time, offer alternative access options, and expand IVL therapy access to patients with larger vessel sizes.
• November 2021, Shockwave Medical Inc. demonstrated the safety and effectiveness of coronary intravascular lithotripsy (IVL) for treating coronary artery disease.

In this report, the Lithotripsy Devices Market has been segmented by Product, Application, End Users and Geography.

Lithotripsy Devices Market, Segmentation by Product

The Lithotripsy Devices Market has been segmented by Product into Extracorporeal Shock Wave Lithotripsy Devices and Intracorporeal Lithotripsy Devices - Laser Lithotripsy Devices, Electrohydraulic Lithotripsy Devices, Ultrasonic Lithotripsy Devices, and Mechanical Lithotripsy Devices.

Extracorporeal Shock Wave Lithotripsy Devices (ESWL)

ESWL devices dominate the lithotripsy devices market, accounting for approximately 60% of total revenue. These non-invasive devices use shock waves to break down kidney stones and are preferred for their minimal recovery time and lower risk of complications.

Intracorporeal Lithotripsy Devices

Intracorporeal lithotripsy devices represent about 40% of the market, encompassing several subtypes based on energy source:

Laser Lithotripsy Devices: Approximate market share: 15%. These use laser energy to precisely fragment urinary stones, offering high efficacy and versatility in different clinical scenarios. Electrohydraulic Lithotripsy Devices: Approximate market share: 10%. Utilizing electrical sparks to generate shock waves, they are effective for hard stone types but are being replaced by newer technologies. Ultrasonic Lithotripsy Devices: Approximate market share: 10%. These use ultrasonic vibrations to break up stones and are often used in combination with aspiration systems for stone removal. Mechanical Lithotripsy Devices: Approximate market share: 5%. These use mechanical force to crush stones and are primarily used in endoscopic procedures for biliary and pancreatic duct stones.

Lithotripsy Devices Market, Segmentation by Application

The Lithotripsy Devices Market has been segmented by Application into Kidney Stones , Ureteral Stones , Pancreatic Stones and Bile Duct Stones.

Kidney Stones

Kidney stones account for approximately 50% of the lithotripsy devices market, driven by the high prevalence of nephrolithiasis and the growing adoption of non-invasive treatment methods such as extracorporeal shock wave lithotripsy (ESWL).

Ureteral Stones

Ureteral stones represent about 25% of total revenue, with intracorporeal lithotripsy devices such as laser and ultrasonic systems widely used for effective stone fragmentation and minimally invasive removal.

Pancreatic Stones

Pancreatic stones contribute nearly 15% of the market, treated with specialized intracorporeal devices and mechanical lithotripsy systems in endoscopic procedures aimed at improving pancreatic duct drainage.

Bile Duct Stones

Bile duct stones account for about 10% of total revenue, with mechanical and electrohydraulic lithotripsy systems used to facilitate stone clearance and endoscopic removal in complex cases.

Lithotripsy Devices Market, Segmentation by End Users

The Lithotripsy Devices Market has been segmented by End Users into Hospitals , Ambulatory Surgical Centers and Other End Users.

Hospitals

Hospitals are the primary end users in the lithotripsy devices market, holding a significant 45.7% share of the global revenue in 2022. Their dominance is attributed to comprehensive infrastructure, including advanced imaging technologies and skilled medical personnel, facilitating effective utilization of lithotripsy procedures. The availability of a wide range of lithotripsy devices in hospital settings ensures optimal patient care and outcomes. Furthermore, hospitals often serve as referral centers for complex cases, reinforcing their central role in the lithotripsy devices market.

Ambulatory Surgical Centers

Ambulatory Surgical Centers (ASCs) are emerging as significant contributors to the lithotripsy devices market, accounting for approximately 35% of the global revenue share in 2022. This growth is driven by the increasing demand for cost-effective and minimally invasive procedures. ASCs offer streamlined services with reduced hospital stays, appealing to patients seeking efficient treatment options. Their specialization in specific medical fields, such as urology, allows for focused expertise in lithotripsy procedures, enhancing patient satisfaction and outcomes.

Other End Users

The "Other End Users" category, encompassing clinics, specialty centers, and research institutions, contributes to around 19.3% of the global lithotripsy devices market revenue in 2022. These facilities play a vital role by providing accessible treatment options in regions where hospitals and ASCs may be limited. Their involvement in clinical research and trials fosters innovation and the development of advanced lithotripsy technologies. While their market share is comparatively smaller, their impact on expanding the reach and capabilities of lithotripsy treatments is significant.

Lithotripsy Devices Market, Segmentation by Geography

In this report, the Lithotripsy Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Lithotripsy Devices Market Share (%), by Geographical Region

North America

North America holds the largest share of the lithotripsy devices market, accounting for approximately 38% of global revenue in 2022. This dominance is driven by advanced healthcare infrastructure, widespread adoption of minimally invasive treatments, and a high prevalence of kidney stone cases. Robust R&D investments and a favorable regulatory environment further strengthen the market position of North America.

Europe

Europe represents a significant portion of the lithotripsy devices market, contributing to around 28% of the total revenue. Factors such as technological advancements, increasing incidence of urolithiasis, and the presence of prominent market players fuel market growth in this region. Strong healthcare systems and rising awareness of non-invasive procedures support continued adoption.

Asia Pacific

Asia Pacific is witnessing rapid growth in the lithotripsy devices market, with an estimated market share of approximately 22% in 2022. The rising geriatric population, growing healthcare expenditure, and increasing prevalence of urinary tract diseases contribute to this upward trajectory. Emerging economies such as China and India present significant growth opportunities due to improving healthcare access and increasing awareness of lithotripsy treatments.

Middle East and Africa

The Middle East and Africa region holds a smaller yet noteworthy share of the lithotripsy devices market, contributing around 7% of the global revenue. Growth in this region is primarily driven by expanding healthcare infrastructure and a rising number of kidney stone cases. Increased government initiatives and partnerships with global players are expected to bolster market expansion in the coming years.

Latin America

Latin America accounts for an estimated 5% of the lithotripsy devices market revenue, driven by growing awareness and improving access to healthcare services. Factors such as the rising prevalence of lifestyle diseases, increasing healthcare investments, and expanding medical tourism contribute to the market's steady growth in this region.

This report provides an in depth analysis of various factors that impact the dynamics of Global Lithotripsy Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers

• Technological advancements in lithotripsy
• Rising prevalence of kidney stones
• Increasing demand for minimally invasive procedures
• Growing geriatric population

• Expanded applications in urology: The global lithotripsy devices market has seen significant expansion in its applications within urology, driven by technological advancements and increasing prevalence of kidney stones. Lithotripsy, a non-invasive procedure used to break down kidney stones into smaller fragments, has become a cornerstone in urological interventions due to its efficacy and reduced patient morbidity compared to traditional surgical methods. With the advent of newer lithotripsy devices utilizing advanced shockwave technology, such as extracorporeal shockwave lithotripsy (ESWL) and intracorporeal lithotripsy, urologists are now able to offer more tailored and minimally invasive treatments to patients suffering from urinary tract stones.

  The global lithotripsy devices market is witnessing a surge in demand fueled by the rising incidence of kidney stone disease worldwide, coupled with growing awareness about the benefits of early intervention. As healthcare infrastructure continues to improve in emerging economies, there's a widening access to lithotripsy procedures, further propelling market growth. Additionally, ongoing research and development efforts aimed at enhancing the precision and effectiveness of lithotripsy devices are expected to drive innovation in the field, opening up new avenues for application and contributing to the continued expansion of the global lithotripsy devices market in urology.

Restraints

• High cost of lithotripsy devices
• Lack of skilled professionals
• Stringent regulatory requirements
• Adverse effects associated with lithotripsy

• Limited accessibility in rural areas: Limited accessibility in rural areas can significantly impact the adoption and availability of advanced medical technologies like lithotripsy devices. These devices are crucial for non-invasive treatment of kidney stones, providing a less invasive alternative to surgery. However, in rural areas where healthcare infrastructure may be lacking, access to such specialized equipment can be limited. This limitation stems from various factors including inadequate healthcare facilities, a shortage of trained medical personnel, and challenges in transportation and logistics. As a result, patients in rural areas may face difficulties in accessing timely and effective treatment for kidney stones, leading to poorer health outcomes and potentially higher healthcare costs in the long term.

  Despite these challenges, the global lithotripsy devices market continues to grow, driven by factors such as increasing prevalence of kidney stones, advancements in lithotripsy technology, and rising demand for minimally invasive procedures. Manufacturers are focusing on developing portable and cost-effective lithotripsy devices that can be deployed in remote and underserved areas, addressing the issue of limited accessibility. Additionally, initiatives by governments and healthcare organizations to improve rural healthcare infrastructure and expand access to medical services are expected to create opportunities for the expansion of the lithotripsy devices market in these regions. Overall, while limited accessibility in rural areas presents challenges, efforts are underway to bridge the gap and ensure equitable access to essential medical technologies like lithotripsy devices.

Opportunities

• Emerging markets in Asia-Pacific
• Development of portable lithotripsy devices
• Collaborations for research and development
• Integration of AI and robotics

• Focus on patient-centric technologies: Patient-centric technologies are revolutionizing the landscape of healthcare, and the lithotripsy devices market is no exception. Lithotripsy, a non-invasive procedure for breaking down kidney stones, is witnessing advancements driven by patient comfort and efficacy. The global lithotripsy devices market is experiencing steady growth, fueled by the increasing prevalence of kidney stones and the demand for minimally invasive treatments. Innovations in lithotripsy technology focus on improving patient outcomes, reducing treatment times, and minimizing side effects. For instance, advancements in shock wave lithotripsy (SWL) machines aim to enhance precision and reduce discomfort for patients. Furthermore, the integration of imaging technologies like ultrasound and fluoroscopy into lithotripsy devices enables real-time visualization, aiding clinicians in accurate stone targeting while ensuring patient safety and comfort.

  Patient-centric approaches in lithotripsy device development extend beyond treatment efficacy to encompass factors like portability, accessibility, and user-friendly interfaces. Manufacturers are investing in the development of compact and mobile lithotripsy devices, allowing treatments to be performed in outpatient settings or even remotely, thereby enhancing patient convenience and reducing healthcare costs. Additionally, integration with telemedicine platforms enables remote monitoring and consultation, further improving the patient experience. As the healthcare industry continues to prioritize patient-centered care, the evolution of lithotripsy devices underscores a commitment to innovation that prioritizes patient comfort, accessibility, and clinical effectiveness.

Key players in Global Lithotripsy Devices Market include:

• Siemens AG
• Storz Medical AG
• Boston Scientific
• Olympus
• Richard Wolf
• Direxgroup
• Novamedtek
• Dornier Medtech
• Medispec
• Walz Elektronik

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis